Vendor, New York, NY
Carelane LLC
UEI WVBLJFGMAU46, CAGE 21EZ6
1 award and $293,829 obligated between September 28, 2026 and September 28, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $293,829 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126C00197Definitive Contract, September 28, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Fy26c3bp6 - Advancing the Development of External Controls for Invasive Fungal INAICS 541715, PSC AN41 | $293,829 |
- Places of performance
- New York
- Product and service codes
- AN41 Health R&D Services; Health Care - Other; Basic Research
- Transactions
- 1 across 1 awards